Integrated LC-MS/MS Method and Network Pharmacology for Exploring the Mechanism of Neuroprotective Effect of Ginsenoside Rc in Oxygen-Glucose Deprivation/Reperfusion Injury-Reference-Cited by-同舟云学术

Integrated LC-MS/MS Method and Network Pharmacology for Exploring the Mechanism of Neuroprotective Effect of Ginsenoside Rc in Oxygen-Glucose Deprivation/Reperfusion Injury

Published:2021-04 Issue:2 Volume:31 Page:207-216
ISSN:1981-528X
Container-title:Revista Brasileira de Farmacognosia
language:en
Short-container-title:Rev. Bras. Farmacogn.

Author:

Huang Mingmin^ORCID,Chen Shaoru^ORCID,Zheng Kening^ORCID,Liu Qu^ORCID,Li Kening^ORCID,Xian Minghua^ORCID,Wang Shumei^ORCID

Funder

The National Natural Science Foundation of China

the National Science and Technology Major Project

the Science and Technology Plan Project of Guangzhou

Publisher

Springer Science and Business Media LLC

Subject

General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s43450-021-00145-6.pdf

Reference39 articles.

1. Ahmed T, Raza SH, Maryam A, Setzer WN, Braidy N, Nabavi SF, Oliveira MR, Nabavi SM (2016) Ginsenoside Rb1 as a neuroprotective agent: a review. Brain Res Bull 125:30–43. https://doi.org/10.1016/j.brainresbull.2016.04.002

2. Armahizer M, Blackman A, Plazak M, Brophy GM (2020) Early acute ischemic stroke management for pharmacists. Hosp Pharm 55:12–25. https://doi.org/10.1177/0018578718791504

3. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233–1244. https://doi.org/10.1161/01.str.28.6.1233

4. Chasman DI, Schürks M, Anttila V, de Vries B, Schminke U, Launer LJ, Terwindt GM, van den Maagdenberg AMJM, Fendrich K, Völzke H, Ernst F, Griffiths LR, Buring JE, Kallela M, Freilinger T, Kubisch C, Ridker PM, Palotie A, Ferrari MD, Hoffmann W, Zee RYL, Kurth T (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 43:695–698. https://doi.org/10.1038/ng.856

5. Choi RJ, Roy A, Jung HJ, Ali MY, Min BS, Park CH, Yokozawa T, Fan TP, Choi JS, Jung HA (2016) BACE1 molecular docking and anti-Alzheimer’s disease activities of ginsenosides. J Ethnopharmacol 190:219–230. https://doi.org/10.1016/J.JEP.2016.06.013